A5026866892- Tracheal and airway disorders
- Respiratory Support and Mechanisms
- Neonatal Respiratory Health Research
- Intensive Care Unit Cognitive Disorders
- Oral health in cancer treatment
- Antifungal resistance and susceptibility
- Fungal Infections and Studies
- Long-Term Effects of COVID-19
The First Hospital of Changsha
2024
Xiangya Hospital Central South University
2024
Central South University
2024
Boston Children's Hospital
2022
Background: Coronavirus disease 2019 (COVID-19) is a respiratory infectious caused by new coronavirus called severe acute syndrome 2 (SARS-CoV-2). It was first reported in Wuhan, China at the end of 2019, and quickly developed into global pandemic. By reviewing clinical data 1 patient with cryptococcus pneumoniae infection after recovered from COVID-19 relevant literature, following possible consequences were discussed corresponding management strategies proposed. Case presentation: A...
Abstract No effective treatments can ameliorate symptoms of long COVID patients. Our study assessed the safety and efficacy human umbilical cord‐derived mesenchymal stem cells (UC‐MSCs) in treatment Ten patients were enrolled received intravenous infusions UC‐MSCs on Days 0, 7, 14. Adverse events clinical recorded, chest‐high‐resolution CT (HRCT) images laboratory parameters analyzed. During follow‐up, we did not observe serious adverse events, significantly relieved a short time, especially...